KariéraCOVID-19
  1. Siemens Healthineers Slovakia
  2. Zobrazovacia diagnostika
  3. Molecular Imaging
  4. MI Trends and Innovations
  5. The Value of Molecular Imaging for Prostate Cancer
Clinical molecular imaging prostate image

The value of molecular imaging for prostate cancer

Molecular imaging without compromise

Prostate cancer facts and figures

globe

Facts to consider

  • 2nd most common cancer after skin cancer1
  • There was an estimated >3.2 million American men living with the disease, in 20091
Incidence of prostate cancer

Incidence

  • Median age at diagnosis is 672 years old
  • 1 in 8 men will be diagnosed with prostate cancer globally during his lifetime2
Prostate cancer facts

Morbidity

  • 32.3% five-year relative survival rate for patients with distant metastasis1
  • 1 in 41 will succumb to prostate cancer1

Theranostics: Personalized care for prostate cancer 

Watch our video:  
A patient's theranostics journey

Follow John as he takes his journey along the theranostics patient pathway to treat his prostate cancer. Meet Dr. Osborne, John's physician, and watch as he describes how he and his team delivered John's personalized prostate cancer treatment. 

Need more information...

Contact us
1
https://seer.cancer.gov/statfacts/html/prost.html
2
https://www.wcrf.org/cancer-trends/prostate-cancer-statistics/

The outcomes achieved by the Siemens Healthineers customers described herein were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (eg, hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results. 


Header image data courtesy of 210 PET Imaging, Cary, North Carolina, USA.